Molecular markers of prognosis in renal cell carcinoma: Insight into tumor biology helps define risk and provides targets for therapy.
Wood
Christopher G
CG
D015703:Antigens, CD / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis; D060890:B7-H1 Antigen; D014408:Biomarkers, Tumor / Q000032:analysis*; D000071231:Carbonic Anhydrase IX; D002256:Carbonic Anhydrases / Q000032:analysis; D002292:Carcinoma, Renal Cell / Q000378:metabolism / Q000556:secondary / Q000628:therapy*; D006801:Humans; D007680:Kidney Neoplasms / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis; D053495:Osteopontin; D011379:Prognosis; D012306:Risk; D012795:Sialoglycoproteins / Q000096:biosynthesis
D015703:Antigens, CD; D000951:Antigens, Neoplasm; D060890:B7-H1 Antigen; D014408:Biomarkers, Tumor; C423236:CD274 protein, human; C506895:SPP1 protein, human; D012795:Sialoglycoproteins; D053495:Osteopontin; C089226:CA9 protein, human; D000071231:Carbonic Anhydrase IX; D002256:Carbonic Anhydrases